Oncotarget Trending with Impact: BRAF Inhibitor vs. Encorafenib in Colorectal Cancer This in vitro study represents the first individual comparison of a tier one drug, encorafenib,... read more October 1, 2020
Oncotarget Novel Study Urges Researchers to Study Pancreatic Cancer in a New Way In this study, researchers performed the first comprehensive analysis of the current landscape of clinical... read more October 1, 2020
Oncotarget New Synergistic Method of Treatment for Select Lymphomas A team of scientists from Columbia University Medical Center has formulated a new, synergistic method... read more September 29, 2020